Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lexapro in Major Depression with ALS or MS
NCT00965497Phase 3Completed
- Sponsor
- University of South Carolina
- Start
- Jul 2009
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of escitalopram in major depressive disorder (MDD), sponsored by University of South Carolina. Primary endpoint: Hamilton Depression Scale at 8 weeks. Started Jul 2009; status: completed.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00965497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00965497.